# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA67356 | 9b | Activity | = | 60.2 | % | ALA888102 | % | Mus musculus | |||
2. | ALA67356 | 9b | Activity | = | 51.8 | % | ALA888099 | % | Mus musculus | |||
3. | ALA67356 | 9b | Inhibition | < | 0 | % | ALA854584 | % | Homo sapiens | |||
4. | ALA67356 | 9b | Inhibition | = | 3.8 | % | ALA854586 | % | Human immunodeficiency virus type 1 group M subtype B (isolate PCV12)(HIV-1) | |||
5. | ALA67356 | 9b | IC50 | = | 74.2 | uM | ALA854587 | 4.13 | nM | Human immunodeficiency virus | ||
6. | ALA67356 | 9b | CC50 | > | 162 | uM | ALA863595 | nM | ||||
7. | ALA67356 | 9b | Ratio CC50/IC50 | > | 2.2 | ALA863596 | Human immunodeficiency virus | |||||
8. | ALA67356 | 9b | Activity | 0 | ALA854585 | Not Determined | ||||||
9. | ALA67356 | 9b | pD'2 | 0 | ALA869013 | Not Determined | Rattus norvegicus | |||||
10. | ALA67356 | 9b | pD'2 | 0 | ALA869012 | Not Determined | Rattus norvegicus | |||||
11. | ALA67356 | 9b | pD'2 | 0 | ALA869011 | Not Determined | Rattus norvegicus | |||||
12. | ALA67356 | 9b | EC50 | 0 | ALA869689 | Not Determined | Rattus norvegicus | |||||
13. | ALA67356 | 9b | Inhibition | 0 | ALA869688 | Not Determined | % | Rattus norvegicus | ||||
14. | ALA67356 | 9b | Inhibition | 0 | ALA869687 | Not Determined | % | Rattus norvegicus | ||||
15. | ALA67356 | 9b | EC50 | 0 | ALA869686 | Not Determined | Rattus norvegicus | |||||
16. | ALA67356 | 9b | Activity | 0 | ALA869685 | Not Determined | Rattus norvegicus | |||||
17. | ALA67356 | 9b | Activity | 0 | ALA869684 | Not Determined | Rattus norvegicus | |||||
18. | ALA67356 | 9b | Index | = | 0.5 | % | ALA842382 | % | Plasmodium falciparum | |||
19. | ALA67356 | 9b | IC50 | = | 7.5 | uM | ALA762015 | 5.12 | nM | Plasmodium falciparum | ||
20. | ALA67356 | 9b | IC50 | = | 2.3 | ug ml-1 | ALA762015 | ug.mL-1 | Plasmodium falciparum |